The external loop linking the M2 and M3 transmembrane domains is crucial for coupling agonist binding to channel gating in the glycine receptor chloride channel (GlyR). A substituted cysteine accessibility scan previously showed that glycine activation increased the surface accessibility of 6 contiguous residues (R271 -K276) towards the N-terminal end of the homomeric α1 GlyR M2-M3 loop. In the present study we used a similar approach to determine whether the allosteric antagonist, picrotoxin, could impose conformational changes to this domain that cannot be induced by varying agonist concentration alone. Picrotoxin slowed the reaction rate of a suflhydryl-containing compound (MTSET) with A272C, S273C and L274C.
The external loop linking the M2 and M3 transmembrane domains is crucial for coupling agonist binding to channel gating in the glycine receptor chloride channel (GlyR). A substituted cysteine accessibility scan previously showed that glycine activation increased the surface accessibility of 6 contiguous residues (R271 -K276) towards the N-terminal end of the homomeric α1 GlyR M2-M3 loop. In the present study we used a similar approach to determine whether the allosteric antagonist, picrotoxin, could impose conformational changes to this domain that cannot be induced by varying agonist concentration alone. Picrotoxin slowed the reaction rate of a suflhydryl-containing compound (MTSET) with A272C, S273C and L274C.
Before interpreting this as a picrotoxin-specific conformational change, it was necessary to eliminate the possibility of steric competition between picrotoxin and MTSET.
Accordingly, we showed that picrotoxin and the structurally-unrelated blocker, bilobalide, were both trapped in the R271C GlyR in the closed state and that a point mutation to the pore-lining T6' residue abolished inhibition by both compounds. We also demonstrated that the picrotoxin dissociation rate was linearly related to the channel open probability. These observations constitute a strong case for picrotoxin binding in the pore. We thus conclude that the picrotoxin-specific effects on the M2-M3 loop are mediated allosterically. This suggests that the M2-M3 loop responds differently to the occupation of different types of binding sites.
The glycine receptor chloride channel (GlyR) 1 mediates inhibitory neurotransmission in the central nervous system (1, 2) . Like other members of the cysteine-loop ligand-gated ion channel (LGIC) family, functional GlyRs comprise 5 subunits arranged symmetrically around a central ion-conducting pore. Each subunit consists of a large extracellular ligandbinding domain followed by 4 α-helical transmembrane domains, termed M1 -M4 (3, 4) .
It is now well-established that the extramembranous loop joining M2 and M3 is crucial for transmitting the agonist-induced conformational change to the M2 domain activation gate (5) (6) (7) (8) . Consistent with this role, a substituted cystine accessibility study on the α1 GlyR showed that the surface accessibility of 6 contiguous cysteine-substituted residues in this loop (R271 to K276) was increased in the open state (9) . Thus, the conformational status of the M2-M3 loop depends on the degree to which the receptor is activated by agonist. However, it is not known whether allosteric modulators could impose conformational changes to this loop that cannot be induced by simply varying the agonist concentration alone. This is an important question as it could reveal a hitherto unexpected complexity in the role of this important domain. In particular, it would address the hypothesis that the M2-M3 loop conformation can be modified in different ways by different ligands.
In this study we address this question by determining whether the closure of the channels by the allosteric inhibitor, picrotoxin (PTX), preserves the relationship between domain conformation and fractional peak current magnitude that is seen in its absence. If this relationship is not preserved, we would conclude that the PTX-induced closed state is conformationally different to the unliganded closed state.
PTX inhibits most anionic LGICs including the recombinant α homomeric GlyR, the GABA type-A receptor (GABA A R) and the invertebrate glutamate receptor Cl -channel (GluClR). PTX is a use-dependent inhibitor of GABA A R (10) and GluClR (11) , but displays no use-dependence at the α homomeric GlyR (12) . PTX inhibition is extremely sensitive to mutations to residues at the 2' and 6' pore-lining positions (11, (13) (14) (15) (16) (17) (18) . Although this implies that PTX binds in the pore, it is unlikely that picrotoxin inhibition is due to classic pore block. Data obtained using a variety of techniques including single channel kinetic and conductance analysis (10, 19) , macroscopic current kinetic analysis (20) , interactions between picrotoxin analogs (21), site-directed mutagenesis (12, 22) and combined fluorescence labelling and electrophysiology (23) together form a strong case that PTX allosterically inhibits anionic
LGICs.
PTX may be a useful modulator for the present investigation as mutations in the M2-M3 loop have profound effects on its mode of action (12) .
Materials and Methods

Mutagenesis and expression of human GlyR α1
subunit cDNAs -Site-directed mutations were incorporated as previously described (9) . The WT and mutant GlyRs investigated in this study incorporated the functionally silent C41A mutation (9) . Plasmid constructs were transiently transfected into HEK293 cells via the calcium phosphate precipitation method. Cells were washed 24 h later, and currents were recorded over the next 72 hrs.
Patch-clamp electrophysiology -Currents were measured using whole-cell recording at a holding potential of -40 mV using an Axopatch 1D amplifier (Axon Instruments, Foster City, CA, USA) and data were directly recorded to disk using pCLAMP 6 or 9 software (Axon Instruments). Cells were perfused with the standard bathing solution containing (in mM): 140 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, 10 glucose, pH 7.4. Patch pipettes had tip resistances of ~1.5 MΩ when filled with the standard intracellular solution containing (in mM): 145 CsCl, 2 CaCl 2 , 2 MgCl 2 , 10 HEPES, 10 EGTA, pH 7.4. PTX and bilobalide (BB) (both from Sigma), were stored as 10-100 mM stock solutions in DMSO for up to 3 months and dissolved into the bath solution on the day of the experiment.
Methanethiosulfonate ethyltrimethylammonium (MTSET), from Toronto Research Chemicals (Toronto, Canada), was prepared as a stock solution of 10 mM in distilled water and maintained on ice for up to 3 hours until used. It was applied to cells within 30 s of being dissolved into room temperature bathing solution. The disulfide reducing agent, dithiothreitol (DTT), was prepared daily as a 1 mM solution in the standard bathing solution. Solutions were applied to cells via a parallel system of gravity-fed tubes, and solution exchange was effected with a time constant of about 100 ms. Experiments were performed at room temperature (19 -22 o C). The effects of MTSET on glycine-gated currents were tested as follows. Prior to MTSET application, cells were bathed in 1 mM DTT for 1 min to ensure that exposed sulfhydryl groups were fully reduced. Then the glycine doseresponse was measured at least 3 times over a period of approximately 10 min to ensure that EC 10 and EC 30 glycine concentrations could reliably be chosen and that the current magnitude was invariant (± 5%) prior to the application of MTSET. Following application of the MTSETcontaining solution, cells were washed in control solution for at least 2 min before the current magnitudes were measured again. This was done to ensure that cysteine modification had taken place. Currents were then reduced to their original control levels by a 1 min exposure to 1 -2 mM DTT.
Data Analysis -Results are expressed as mean ± standard error of the mean (SEM) of 3 or more independent experiments. The empirical Hill equation, fitted by a non-linear least squares algorithm (Sigmaplot 9.0, Systat Software Inc, Richmond, CA, USA), was used to calculate the 50% effective concentrations for PTX inhibition (IC 50 ) and the Hill coefficient (n H ) values. Exponential fits were performed using the same non-linear least squares algorithm. Statistical significance was determined by Student's paired or unpaired t-test (as indicated) with P < 0.05 representing significance.
Results
PTX interactions with the M2-M3 loop
The peak current magnitudes and glycine EC 50 values for all mutant GlyRs examined in this study have previously been published (9) . Since the present study concerns the effects of PTX on M2-M3 loop conformation, it was first necessary to measure the mean PTX IC 50 and n H values for the WT and all cysteine-substituted GlyRs. Sample recordings from cells expressing each mutant GlyR examined in this study are shown in Fig. 1A . These show the effects on increasing concentrations of PTX on currents activated by EC 30 -EC 50 glycine concentrations. Averaged PTX dose-responses are displayed in Fig 1B ( separated into 2 panels for clarity) and the mean IC 50 and n H values are summarized in Table 1 , together with the glycine concentration at which each was measured. These results reveal two general features. First, as shown in Table 1 , the n H values for all cysteine mutants were < 1, which is significantly less than the n H value for the WT GlyR of around 1.5. These results imply that PTX inhibits the WT GlyR in a cooperative manner, but that this cooperativity is lost when mutations are incorporated into the Nterminal half of the M2-M3 loop. Mutagenesis also significantly increased the PTX sensitivity of most mutants, except for A272C where there was no significant difference, and L274C where there was an approximately 5-fold reduction in PTX sensitivity. In agreement with a previous report (12) , these results indicate that loop mutations affect the allosteric actions of PTX, but they provide no evidence for the direct disruption of a PTX binding site.
Our original aim was to determine the effect of PTX on the MTSET reactivity of cysteines introduced individually to positions 271 -276 in the α1 GlyR. We previously demonstrated that the MTSET reaction rates for all cysteine-substituted mutants are increased in the channel open state (9) . To assess the effect of PTX on cystine accessibility, we first measured the MTSET reaction rates of all mutants at the EC 10 and EC 30 glycine concentrations. (As MTSET reaction rate is proportional to the degree of receptor activation, we expect this to increase with increasing glycine concentration.)
We then added a sufficient concentration of PTX to the EC 30 glycine concentration to inhibit the current to the EC 10 current magnitude. If the MTSET reaction rate depends only on the channel open probability, then the reaction rates in the presence of PTX + EC 30 glycine should be identical to its reaction rate in the presence of EC 10 glycine.
However, if the respective reaction rates are different, it may be possible to conclude that PTX promotes a conformational state that cannot be attained by glycine.
An example of such an experiment performed on the S273C mutant GlyR is shown in Fig. 2A . All traces in this figure are from the same cell. The upper left panel shows the effect of 100 µM MTSET applied in the presence of an EC 10 (in this case 30 µM) concentration of glycine. A 2 min wash in control solution had no effect, although the MTSET-induced current increase was completely reversed by a 1 min exposure to 1 mM of the reducing agent, DTT ( The same experimental protocol was applied to 2 other cells expressing the S273C mutant GlyR and the averaged results are summarized in Fig. 2B . These results are normalized to the MTSET reaction rate measured in the presence of EC 10 glycine. A paired t-test (P < 0.05) indicates that 10 µM PTX + EC 30 glycine caused a significant reduction in the MTSET reaction rate with S273C relative to that caused by EC 10 glycine (Fig. 2B) .
We used a similar protocol to examine the effect of PTX on MTSET reaction rates with the R271C, A272C, L274C, P275C and K276C mutant GlyRs. In the A272C and L274C mutant GlyRs, PTX + EC 30 glycine also caused a significant reduction in the reaction rate relative to that seen in the presence of EC 10 glycine alone (Fig. 2B ). However, in the P275C GlyR, the reaction rate in PTX + EC 30 glycine was not significantly different to that obtained with EC 10 glycine (Fig. 2B, Fig. 3A ). This negative result was confirmed in each of 5 cells and the averaged results are shown in Fig. 2B . This result is not surprising as the reaction rate differential between the closed state and EC 30 glycine-activated state in this mutant is less than 3-fold (9) , implying that the surface exposure of P275C varies little during gating.
The effects of PTX on MTSET reactivity of R271C and K276C could not be measured.
As shown in the example in Fig. 3B , an increase in the R271C reaction rate was observed as the glycine concentration was increased from EC 10 to EC 30 . Surprisingly, however, PTX abolished the change in current that otherwise occurs upon the addition of MTSET to these mutants (Fig.  3B , bottom trace). A similar lack of effect was observed in each of 4 cells expressing the R271C GlyR and in 4 cells expressing the K276C GlyR. There are 2 likely explanations for this. One is that MTSET cannot reach its reaction site in the presence of PTX and the other is that MTSET modification caused an increase in PTX sensitivity, so that the enhanced PTX inhibition exactly cancelled out the MTSET-induced current increase. If both MTSET and PTX are removed following simultaneous exposure, the magnitude of the glycine-activated current increases to the same value as seen following exposure to MTSET in the absence of PTX (Fig.  3B , compare center and bottom traces). This indicates that MTSET modification has taken place and that MTSET modification must therefore cause an increased PTX sensitivity in the R271C GlyR. This was tested directly by measuring the degree of inhibition induced by 10 µM PTX on currents activated by 3 mM glycine both before and after MTSET modification. Before MTSET, PTX inhibited currents to 51 ± 3 % of control, but in the same 4 cells after MTSET modification, it inhibited currents to 28 ± 7 % of control.
This difference was statistically significant (P < 0.05) using a paired t-test. A similar experiment performed on the K276C GlyR yielded a similar result. A 10 mM PTX concentration inhibited currents activated by 5 mM glycine to a level of 35 ± 6 % before MTSET modification and to 10 ± 3 % after modification.
Again, this difference was statistically significant using a paired t-test (n = 4 cells, P < 0.05). Hence, it is concluded that the lack of current change upon simultaneous application of MTSET + PTX can be attributed to an MTSET-induced increase in PTX sensitivity.
The conclusion thus far is that PTX reduces the reaction rate of MTSET with A272C, S273C and L274C. There are 3 possible ways by which this could be achieved. The first is that PTX and MTSET may form a complex in free solution. This possibility was eliminated by showing that the PTX IC 50 for the WT GlyR was not significantly affected by the presence of 1 mM MTSET (not shown).
The second possibility is that PTX changes the conformation of this domain via an allosteric action. The third is that PTX binds to either this domain or a nearby domain and sterically interferes with the MTSET reaction. To discriminate between these two possibilities, it is essential to identify the location of the PTX binding site.
PTX interactions with the pore
During the course of the above experiments, we noticed that recovery from PTX inhibition required the R271C GlyR to be activated by glycine. This effect is characterized formally in Fig. 4 . Fig 4A shows a control in which 2 applications of an EC 50 (3 mM) concentration of glycine spaced ~ 60 s apart are similar in magnitude. Fig 4B shows the slow recovery that follows the complete inhibition of this current by a saturating (300 µM) concentration of PTX. If both glycine and PTX are simultaneously removed when the current is inhibited, it is apparent that recovery from PTX inhibition commences only when glycine is applied 60 s later (Fig. 4C) . Thus, PTX is 'trapped' in the absence of glycine. As shown in the inset, overlay of the PTX inhibition recovery phases recorded in Figs 4B and C reveal identical time-courses of recovery. When PTX is applied in the closed state (Fig. 4D) , a subsequent application of glycine indicates that PTX cannot efficiently access its inhibitory site. Identical experiments to these were performed in each of 5 cells, and the results are summarized in Fig. 4E and F. Fig. 4E shows the percentage of original current that is observed 65 s after the initial glycine current is terminated for the 4 experimental conditions depicted in Fig. 4A-D . The 0 and 65 s time points are indicated by the vertical dashed line. Fig. 3E reveals that the only condition that causes a significant decrease in glycine current at the 65 s time point is when PTX is trapped for 60 s in the closed state. Fig.  3F measures the ratio of currents from 5 cells measured at 1 s intervals during the recovery from PTX inhibition following trap relative to the current recorded at the same recovery time point without trap. As there is no substantial deviation from 1 at any point, we conclude that the recovery rate following 60 s trap is no different from its recovery rate without trap.
We also observed PTX trap in the MTSET-modified R271C GlyR and the K276C GlyR (n=3 for each, data not shown), but not in any other mutant GlyR tested in this study.
PTX has long been hypothesized to bind in the GlyR pore (24) . However, as discussed below, the evidence supporting this is not overwhelming. Nevertheless, on the basis of the PTX trap observation, we retained the hypothesis that PTX binds in the pore, and we designed several experiments to test this.
The first of these is summarised in Fig.  5 . We reasoned that if PTX can escape from the R271C GlyR pore in the open state only, then its recovery rate should be proportional to the channel open probability. To test this, currents activated by 0.3, 1, 3, 10 and 20 mM glycine were completely inhibited by 300 µM PTX and the time course of the recovery current was recorded. An example of one such experiment is displayed in Fig. 5A . The number of exponential terms needed to adequately fit the recovery phase varied from cell to cell due to the variable presence of a small rapidly recovering current component. As a maximum of around 10% of the current recovers by this fast pathway, it is ignored for the purpose of this analysis and a single exponential curve was fit only to the remaining slow recovery phase.
The time constants averaged from 4 cells reveal a consistent relationship between recovery rate and glycine concentration (Fig. 5B) . The same data are plotted in a different way in Fig. 5C . In this analysis, we made use of the fact that 20 mM glycine is saturating at the R271C GlyR (9). We then expressed the current magnitudes activated by 1, 3 and 10 mM as a fraction of the saturating current in each cell and plotted this against the inverse of the dissociation time constant (i.e., dissociation rate). The pooled results, displayed in Fig. 5C , were well fitted by a linear regression with a regression coefficient of 0.79, implying a linear relation between the PTX unbinding rate and channel open probability.
Such a relationship is expected for a molecule than can escape from its site only in the open state. However, this linearity is disrupted at open probabilities less than around 0.2, implying that PTX cannot easily escape during the fast opening events typical of weakly liganded GlyRs (25) .
We then reasoned that if PTX is trapped in the pore of the R271C GlyR, then other putative pore-blocking substances with unrelated structures should also be trapped. There are two families of molecules that block GlyRs: cyanotriphenylborate (26) and several structurally-related extracts from Gingko biloba leaves (27, 28) . In this study, we used the sesquiterpene trilactone Gingko component, BB. Sample responses to increasing concentrations of BB on WT GlyR currents are shown in Fig. 6A (left panel), and the averaged dose-response pooled from 4 cells is shown in Fig. 6A (right  panel) . The mean BB IC 50 was 19.6 ± 1.6 µM and the n H value was 0.58 ± 0.06 (both n = 4). As the Gingko biloba derivatives have only been tested on native GlyRs with unknown subunit compositions, it was first necessary to confirm that BB inhibited the recombinantly expressed GlyR α homomer in a use-dependent manner. This was performed as indicated in Fig. 6B . The upper and lower left panels show the effects of 10 µM BB applied in the closed and open states, respectively. As seen in the lower panel, glycine-induced current activation following BB removal is slow as a result of the slow dissociation of BB. If BB accesses its site equally well in the closed state, the rate at which glycine activates the channels after a closed state BB application should be slowed to a similar extent. To facilitate comparison of glycineactivation rates, the activation segments under each experimental condition (as indicated by numbers 1, 2 and 3) are normalized, superimposed and expanded in Fig. 6B upper right panel. Single exponentials were fit to these curves and the time constants averaged from 4 cells are averaged in Fig. 6B, lower In contrast, the same experiment performed using PTX demonstrated rapid access to its site in the closed state (12) . Thus, BB is a use-dependent inhibitor of recombinant α homomeric GlyRs.
We next sought to determine whether the effects of PTX and BB were mediated by common molecular determinants. The T6'F mutation has previously been shown to drastically reduce the PTX inhibitory potency (18, 29) . Sample responses of WT and T6'F mutant GlyR currents to high concentrations of PTX and BB are shown in Fig. 6C . We found in each of 4 cells that 300 µM BB had no significant inhibitory effect on currents activated by an EC 50 concentration (5 µM) of glycine in the T6'F mutant GlyR. Full BB dose-responses were not measured in the T6'F GlyR due to its low sensitivity and the limited quantity of the compound.
Nevertheless, these results demonstrate a marked similarity in the mechanisms of action of PTX and BB. The final test was to determine whether BB is trapped in the closed state of the R271C GlyR. The results of this experiment are summarized in Fig. 7 . As with PTX inhibition, recovery from BB inhibition was slow (Fig. 7A) , and the 60 s delay in the addition of glycine indeed demonstrated that BB is trapped in the pore (Fig.  7B) . Note, however, that the delayed addition of glycine was associated with a small step jump in current that is not present in the corresponding trace in Fig. 7A . This effect was observed in all 3 cells in which it was investigated and indicates that BB can escape slowly from its site in the closed state. However, as shown in Fig. 7C , BB cannot efficiently reach its inhibitory site in the closed state. In order to average recovery currents from multiple cells, we first superimposed the recovery currents recorded with and without trap. This is shown in Fig. 7D , upper panel, where currents are aligned according to the time that glycine-induced recovery was initiated (asterisk). This clearly displays the step and the subsequent offset it induces in the recovery phase. To compensate for this offset, the curves were moved laterally to each other until they overlapped maximally ( Fig  7D, lower panel) . The ratio of these currents at 1 s intervals during recovery was then calculated, with the average from 3 cells displayed in Fig.  7E . This indicates that apart from the small step current due to slow BB escape, a period of trap does not affect the recovery rate from BBmediated inhibition.
Discussion
A binding site for PTX in the pore?
PTX significantly slowed the MTSET reaction rate with the A272C, S273C and L274C GlyRs. Before interpreting this as a PTXinduced conformational change, we must first eliminate the possibility that the effect was due to steric competition between PTX and MTSET. Hence, this discussion first considers the location of the PTX binding site.
PTX has long been thought to bind in the GlyR pore (24, 30) .
The main evidence in favour of this is that mutations at the 6' porelining position can either abolish PTX sensitivity in the PTX-sensitive α1 GlyR, or drastically enhance PTX sensitivity in the PTX-insensitive α1β GlyR (18) . The main evidence against a pore binding site hypothesis is that PTX inhibition of the GlyR is not use-dependent. That is, PTX accesses its inhibitory site efficiently in the closed state. Indeed, its inhibitory potency is stronger at low, weaklyactivating glycine concentrations than at saturating glycine concentrations (12) . These characteristics are the opposite of those usually associated with molecules that bind deep in a pore.
On the other hand, however, PTX inhibition is use-dependent in the structurallyrelated GABA A R and GluClRs (10, 11, 17, 22) .
Furthermore, mutagenesis of a divergent S15' residue in the α1 GlyR pore-lining domain back towards the corresponding residues in the GABA A R β subunit or GluClR β subunit (via the S15'N and S15'Q mutations, respectively) converts PTX into a use-dependent inhibitor of the GlyR (22) . Although broadly consistent with a pore binding site for PTX, the above evidence does not constitute a conclusive case for PTX binding in the pore.
We demonstrate here that the R271C GlyR must be opened for PTX to access or leave its binding site. The dissociation rate of PTX is linearly proportional to the open probability over the range 20 -100 % of its maximum value, but is substantially reduced at lower open probabilities (Fig. 5C ). These properties are expected if PTX binds in the pore. Similar blocker trap behaviour has been observed in a variety of cation-selective channels (31-34), although such phenomena have rarely been described in proteins that do not possess a pore or deep crevice. The present study also shows that mutation of the T6' pore-lining residue abolishes sensitivity to both PTX and the structurally-unrelated pore blocker, BB. The fact that a single molecular determinant is crucial for the efficacy of both compounds implies that they share a common mode or site of action. Indeed, T6' has already been proposed as a PTX contact site and a molecular modelling study indicates that PTX can plausibly bind in this location (30). Furthermore, by showing that BB is trapped by the R271C GlyR, we demonstrate that the trap effect does not discriminate on the basis of molecular structure. This is consistent with both molecules binding in the pore, but would be difficult to reconcile with them binding to separate sites in an extramembranous part of the protein. Finally, we have previously shown that T6'C is functionally modified by MTSET in the open state only (18) . This provides independent evidence for a narrow pore constriction external to T6'C in the closed state. Together, these lines of evidence constitute a strong, but not definitive, case for PTX binding in the pore of the R271C GlyR.
Our experiments do not directly address why BB inhibition of the WT GlyR is usedependent whereas PTX inhibition is not. We propose that PTX efficiently accesses its site in the closed state (12) and allosterically inhibits the GlyR by stabilising a 'closed pore' conformation. BB may also have efficient access to the 6' depth in the closed state, although we propose it requires the channel to be opened in order for it to bind.
Why is PTX trapped in the pore of the R271C GlyR but not the WT GlyR? The recent structural model of the T. marmorata nicotinic acetylcholine receptor (nAChR) transmembrane domains shows a band of hydrophobic residues around the middle of the M2 domain extending from L9' to V13'(8, 35) These residues are linked to the adjacent residues on neighbouring subunits by hydrophobic bonds, and thus form a central pore constriction that holds the channel closed.
Note that this constriction is not necessarily the gate that controls ion flow. Evidence from substituted cysteine accessibility studies implies that the ion gate lies in the -2' to 2' region in the nAChR and GABA A R (36-38), although it may be centrally located in the 5HT 3 -gated cation channel (39, 40). We propose that the centrally located gate does not form a substantial barrier to PTX access in the WT GlyR in the closed state. However, PTX is converted into a use-dependent inhibitor of the GlyR by mutations to S15' (22) and to R271C and K276C in the M2-M3 loop (present study). We propose these mutations disrupt M2 structure, leading to an even smaller constriction at the pore midpoint. Thus, the pore must be opened to permit the passage of large molecules like PTX. The idea that changes in conformation of the M2-M3 loop lead to a conformational change at the pore midpoint is a common feature of all models proposed so far to explain LGIC activation (3, (41) (42) (43) (44) .
A PTX-specific conformation change
By binding in the pore, PTX cannot sterically hinder MTSET from reacting with M2-M3 loop cysteines. We therefore conclude that PTX changes the MTSET reaction rate by changing the intrinsic reactivity rates of the introduced cysteines. This study has shown that a given relative peak current magnitude (or EC value) is associated with a fixed cysteine reaction rate for each mutant GlyR. Because PTX changes the relationship between EC and cysteine reactivity, we conclude that it alters the M2-M3 loop structure in a way that cannot be achieved by glycine. This conclusion has important implications for our understanding of LGIC activation mechanisms. Our current understanding is that agonist binding causes conformational change in the extracellular ligand-binding domain and this is transmitted to the channel gate via conformational changes in the M2-M3 loop (2, 3, 43, 44).
Because allosterically-acting modulators also cause global changes in receptor conformation, it is expected that these should also alter M2-M3 loop conformation. However, until now there has been no evidence to suggest that allosteric modulators could act in any other way than by stabilizing the M2-M3 loop in either the glycineliganded open conformation or the glycine-free closed conformation.
Thus, the crucial insight of this study is that PTX can alter the conformation of the GlyR M2-M3 loop in a way that cannot be achieved by simply varying the glycine concentration alone. This result reveals a hitherto unexpected complexity in the role of the M2-M3 loop. Our results also validate the R271C GlyR as a tool for establishing whether or not molecules bind in the pore.
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Phillips, L.R., and Nichols, C.G. * Significantly different from WT value using an unpaired t-test (P < 0.05). Table 1 . B. Averaged PTX dose-response curves from the WT GlyR, plus the R271C, A272C and S273C GlyRs (left panel), and the L274C, P275C and K276C GlyRs (right panel). The parameters of best fit averaged from individual dose-response curves are summarized in Table 1 . Sample results for P275C and R271C using protocol as described in Fig. 2A . A. All data in this panel were recorded from a cell expressing the P275C GlyR. In this cell, glycine was applied at 1 and 3 mM (corresponding to EC 10 and EC 30 ), and PTX was applied at 10 µM. Note the apparent lack of effect of glycine concentration and PTX on MTSET reaction rate. Data averaged from 5 cells confirms this (Fig. 2B) . B. All data in this panel were recorded from a cell expressing the R271C GlyR. The experimental protocol in upper 2 panels was the same Fig. 2A . In this cell, glycine was applied at 1 and 3 mM and PTX was applied at 10 µM. In the bottom panel, control glycine applications before and after MTSET reveal that MTSET did induce a current increase that became apparent only after PTX washout. by guest on November 4, 2016
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